Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
暂无分享,去创建一个
[1] I. Chang,et al. Resistance of Mitochondrial DNA-depleted Cells against Cell Death , 2004, Journal of Biological Chemistry.
[2] Tadao Tanaka,et al. Enhancement of sensitivity to cisplatin by orobol is associated with increased mitochondrial cytochrome c release in human ovarian carcinoma cells. , 2003, Gynecologic oncology.
[3] S. Isonishi,et al. Mitochondria in platinum resistant cells. , 2001, Human cell.
[4] G. Cohen,et al. Apoptotic death sensor: an organelle's alter ego? , 2001, Trends in pharmacological sciences.
[5] P. Majumder,et al. Targeting of Protein Kinase C to Mitochondria in the Oxidative Stress Response 1 , 2001 .
[6] W. Earnshaw,et al. Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.
[7] A. Grothey,et al. Cisplatin resistance and oncogenes - a review , 2000, Anti-cancer drugs.
[8] Keshav K. Singh,et al. Mitochondrial DNA determines the cellular response to cancer therapeutic agents , 1999, Oncogene.
[9] J. Meléndez-Zajgla,et al. Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin , 1999, Biochemistry and molecular biology international.
[10] B. Liang,et al. Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion , 1998, Cell Death and Differentiation.
[11] M. Poirier,et al. Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. , 1997, Mutation research.
[12] W. Dalton,et al. Selection for drug resistance results in resistance to Fas-mediated apoptosis. , 1997, Blood.
[13] D. Gustafson,et al. A new cellular target for mitomycin C: a case for mitochondrial DNA. , 1997, Oncology research.
[14] I. Herr,et al. Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.
[15] Guido Kroemer,et al. The biochemistry of programmed cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] V. Bohr,et al. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. , 1992, Carcinogenesis.
[17] P. Andrews,et al. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. , 1992, Cancer research.
[18] B. Teicher,et al. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). , 1990, The Journal of biological chemistry.
[19] S. Howell,et al. Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. , 1990, The Journal of biological chemistry.
[20] M. D. Topal,et al. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. , 1988, The Journal of biological chemistry.
[21] J. Aprille,et al. Relation of mevalonate synthesis to mitochondrial ubiquinone content and respiratory function in cultured neuroblastoma cells. , 1985, The Journal of biological chemistry.